Publications (29) Publications auxquelles un chercheur a participé

2024

  1. Cardiometabolic risk stratification using a novel obesity phenotyping system based on body adiposity and waist circumference

    European Journal of Internal Medicine, Vol. 124, pp. 54-60

  2. Consenso del grupo de trabajo de los trastornos de la conducta alimentaria de SENPE (GTTCA-SENPE). Evaluación y tratamiento médico-nutricional en la anorexia nerviosa. Actualización 2023

    Nutricion hospitalaria, Vol. 41, Núm. 1, pp. 1-60

  3. Decreased expression of the NLRP6 inflammasome is associated with increased intestinal permeability and inflammation in obesity with type 2 diabetes

    Cellular and Molecular Life Sciences, Vol. 81, Núm. 1

  4. Differences in the clinical and hormonal presentation of patients with familial and sporadic primary aldosteronism

    Frontiers in Endocrinology, Vol. 15

  5. Does the Prevalence of Obesity in the Different Regions of Spain Influence the Attitudes, Perception, and Barriers to Its Treatment?

    Obesity Facts, Vol. 17, Núm. 3, pp. 264-273

  6. EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

    Obesity Facts, Vol. 17, Núm. 4, pp. 374-444

  7. EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)

    Journal of Hepatology, Vol. 81, Núm. 3, pp. 492-542

  8. Enhancing the management of chronic diseases in clinical practice: The CARABELA methodology

    Journal of Healthcare Quality Research

  9. Epicardial and liver fat implications in albuminuria: a retrospective study

    Cardiovascular Diabetology, Vol. 23, Núm. 1

  10. FNDC4 reduces hepatocyte inflammatory cell death via AMPKα in metabolic dysfunction-associated steatotic liver disease

    Clinical Nutrition, Vol. 43, Núm. 9, pp. 2221-2233

  11. Gut microbes in metabolic disturbances. Promising role for therapeutic manipulations?

    European Journal of Internal Medicine, Vol. 119, pp. 13-30

  12. Impact of primary aldosteronism on kidney function: Results from the SPAIN-ALDO registry

    Journal of Hypertension, Vol. 42, Núm. 10, pp. 1805-1812

  13. Increasing the complexity of lipoprotein characterization for cardiovascular risk in type 2 diabetes

    European Journal of Clinical Investigation, Vol. 54, Núm. 8

  14. Is adrenal venous sampling always necessary to differentiate between unilateral and bilateral primary aldosteronism? Lesson from the SPAIN-ALDO register

    Endocrine, Vol. 84, Núm. 2, pp. 683-693

  15. Localization, traffic and function of Rab34 in adipocyte lipid and endocrine functions

    Journal of Biomedical Science, Vol. 31, Núm. 1

  16. Metabolic dysfunction-associated steatohepatitis (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) require urgent attention by primary care physicians and endocrinologists

    Endocrinologia, Diabetes y Nutricion, Vol. 71, Núm. 4, pp. 149-151

  17. Multidisciplinary Delphi consensus on challenges and key factors for an optimal care model in chronic kidney disease

    Nefrologia, Vol. 44, Núm. 5, pp. 678-688

  18. Patients' Persistent Symptoms, Clinician Demographics, and Geo-Economic Factors Are Associated with Choice of Therapy for Hypothyroidism by European Thyroid Specialists: The “THESIS” Collaboration

    Thyroid, Vol. 34, Núm. 4, pp. 429-441

  19. Renin as a Biomarker to Guide Medical Treatment in Primary Aldosteronism Patients. Findings from the SPAIN-ALDO Registry

    High Blood Pressure and Cardiovascular Prevention, Vol. 31, Núm. 1, pp. 43-53

  20. Revisiting the beyond BMI paradigm in excess weight diagnosis and management: A call to action

    European Journal of Clinical Investigation, Vol. 54, Núm. 7